![Abraham Scaria](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abraham Scaria
Chief Tech/Sci/R&D Officer at
APPLIED GENETIC TECHNOLOGIES CORPORATION
Profile
Abraham Scaria is Chief Scientific Officer at Beacon Therapeutics (USA), Inc. since 2021.
Former positions include Senior Scientific Director-Gene Therapy at Genzyme Corp., Chief Scientific Officer at IVERIC bio, Inc., Head-Gene Therapy Research at Sanofi Corp., and Vice President & Head-Ophthalmology at Casebia Therapeutics LLC.
Education includes a graduate degree from the University of Mumbai and a doctorate from The Indiana University School of Medicine.
Abraham Scaria active positions
| Companies | Position | Start |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | 15/11/2021 |
Former positions of Abraham Scaria
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Corporate Officer/Principal | - |
Sanofi Corp.
 Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a healthcare company that aims to improve people's lives through science by discovering, developing, and delivering medicines and vaccines for millions of people around the world. The company is comprised of four business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. With over 100,000 employees around the globe, Sanofi is dedicated to chasing the miracles of science to improve the lives of millions of patients. The company is based in Bridgewater, NJ. | Corporate Officer/Principal | - |
| IVERIC BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Abraham Scaria
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Corp.
Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a healthcare company that aims to improve people's lives through science by discovering, developing, and delivering medicines and vaccines for millions of people around the world. The company is comprised of four business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. With over 100,000 employees around the globe, Sanofi is dedicated to chasing the miracles of science to improve the lives of millions of patients. The company is based in Bridgewater, NJ. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Health Technology |
- Stock Market
- Insiders
- Abraham Scaria
